Filing Details

Accession Number:
0001209191-17-054232
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-28 14:45:12
Reporting Period:
2017-09-27
Accepted Time:
2017-09-28 14:45:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
19411 Magellan Health Inc MGLN Services-Hospitals (8060) 581076937
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647234 Mostafa Kamal 15950 North 76Th Street
Suite 200
Scottsdale AZ 85260
Ceo, Magellan Rx Management No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Common Stock, $0.01 Par Value Acquisiton 2017-09-27 11,819 $60.55 11,819 No 4 X Direct
Ordinary Common Stock, $0.01 Par Value Acquisiton 2017-09-27 7,307 $64.87 19,126 No 4 X Direct
Ordinary Common Stock, $0.01 Par Value Disposition 2017-09-27 18,526 $85.31 600 No 4 S Direct
Ordinary Common Stock, $0.01 Par Value Disposition 2017-09-27 600 $86.06 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 X Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-09-27 11,819 $0.00 11,819 $60.55
Common Stock Stock Option (right to buy) Disposition 2017-09-27 7,307 $0.00 7,307 $64.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,514 2025-08-03 No 4 X Direct
14,613 2026-03-03 No 4 X Direct
Footnotes
  1. This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
  2. The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $85.00 to $85.975, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
  3. The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $86.00 to $86.125, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
  4. Of the 50,000 stock options granted, 33,333 are currently vested and exercisable. The remainder of 16,666 options shall vest on August 3, 2018.
  5. Not applicable.
  6. Of the 21,920 stock options granted, 7,307 are currently vested and exercisable. The remainder of 14,613 options shall vest in one half increments on March 3 of 2018 and 2019.